AI주식인사이트AI Stock Insight
B

오스테오닉

226400KOSDAQ의료용 기기 제조업

61.3 / 100

Reference Date: 2026-07-24

Financial Score23.0 / 40
News Sentiment21.3 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Rose 12.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Osteonic produces and sells medical devices (implants) made of metal or biocompatible materials, used for bone fixation, replacement, and adjustment in various body parts such as the skull, jaw, trauma sites, and joints. While metal-based products dominate sales, biocomposite materials are gaining increasing share.

Number of Employees

197people

Average Salary

41.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
12.30Industry Average 20.046.5Point

Lower than industry avg (good)

PBR
1.41Industry Average 1.142.5Point

Higher than industry avg (caution)

ROE
11.82Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
19.29Industry Average 11.650.5Point

1.7x industry avg (risky)

Trend 2023~20259.5 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲27.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲35.5% (2-year basis)

ROE Trend
3.5 / 4

Avg ROE 10.1% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (19%, downtrend)

Current 4,600Won52-week high 8,14052-week low 3,745
1-month return5.0Point

1m +12.20% (rising)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral임시주주총회결과2026-06-26
  • Neutral[기재정정]사업보고서 (2025.12)2026-06-26